Prospective observational study validating the German version of the Control of Allergic Rhinitis and Asthma Test (CARAT10)

Prospective observational study validating the German version of the Control of Allergic Rhinitis and Asthma Test (CARAT10)Prospective observational study validating the German version of the Control of Allergic Rhinitis and Asthma Test (CARAT10), Published online: 04 December 2018; doi:10.1038/s41533-018-0112-8A newly-translated German version of a two-factor asthma test shows promise as a reliable tool for assessing disease control. Asthma frequently co-exists with allergic rhinitis (AR), a condition in which allergies cause irritation and inflammation of the nasal passages. To verify asthma control under AR, a Portuguese team developed the Control of Allergic Rhinitis and Asthma Test (CARAT10). Now, Christoph Ulrich Werner at the Technical University of Munich in Germany and co-workers have translated CARAT10 into German and verified its reliability and validity for use in the German population. The team trialed their CARAT10 version with 213 patients, 101 of whom had concurrent AR, and compared the results with three standardised asthma questionnaires. They found that CARAT10 was a better fit to verify disease control for patients with co-existing AR than in such.

Source: npj Primary Care Respiratory Medicine - December 4, 2018 Category: Primary Care Authors: Christoph Ulrich Werner Luisa Koch Klaus Linde Levente Kriston Konrad Schultz Oxana Atmann Antonius Schneider Source Type: research